| Tag | Content |
|---|
EnhancerAtlas ID | HS170-00157 |
Organism | Homo sapiens |
Tissue/cell | RS4-11 |
Coordinate | chr1:117082690-117083540 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Lhx3 | MA0135.1 | chr1:117083419-117083432 | ATTTAATTAATTT | - | 6.07 | | REL | MA0101.1 | chr1:117082845-117082855 | GGAAATCCCC | - | 6.02 | | SPI1 | MA0080.4 | chr1:117082956-117082970 | GACTTCCTCTTTTC | - | 6.63 | | SPIC | MA0687.1 | chr1:117082956-117082970 | GACTTCCTCTTTTC | - | 6.73 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09788 | chr1:117079120-117088914 | CD14 | | SE_19688 | chr1:117081581-117083146 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_32513 | chr1:117080479-117089910 | GM12878 | | SE_59077 | chr1:117079459-117152311 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I116539 | chr1 | 117082540 | 117083492 |
|
Enhancer Sequence | CATCATCTGA GATGTGATGA AGGTCCATAA AAAGATGGGA AAGGACTAAT AAACCTCAGA 60
AGTAGAAATT TTAAGGGGAC TTTTGGGTAT GGAGGAAAGC CAGATCTCAA TGTACACACA 120
GAAGGAAGTG GATGCCCTGA ATTTAGGAAG TGCCAGGAAA TCCCCCTGTC CAAAATATGC 180
TCACTGGAAG TCTCCTATTA GGTCTGGTGT CTCTAGAAGA TTACCAGGTT ACTAAAACAA 240
GTGTTAACAT TACCTCAAGG AAGTATGACT TCCTCTTTTC TTAAAAAAAA AAAAAAATAG 300
TATGACCAAT CATTTTATCA TGCAGATGTG AAACCTAGAG TCATCTTATG TCTTTTTACA 360
ACCAAAACCT ACATCTTGCA GACTCTTTCT TGGACCCTCT ATCTACCTGG ATGATAGTAG 420
CTTCTAACTT GACATCTCCT CTCTTTAATC CATCATAAGT ATGCACCATC ACATTAATCT 480
TCCAAAAATG TATTTTATCA AGTCACTTCC TTGCTCCAGT ATAGGACACA ATGGCTCCCC 540
ACTGCTACAA GCTGATGTCC AGACTCTCAA ACCAGGACTT TAAGTCCCAC ACTCAATACT 600
ATCAATATCA CTGCCTCCTG ATCAAAACTC ACCTCCCCTG TACTTTACTC CTCTGCAGGC 660
TTCCTAAGGT CTATCCAGTT GGTCTGACTA ACAAAACCAT ACCTTTGCTG AGGTGCCATA 720
GAATATTTTA TTTAATTAAT TTATTTAGCT AGTTATTTTG AGGCAGGGTC TTGGTCTGTC 780
ACCCAGACTG GAGTGCAGAG GTGCAATCAT GGCTCACTGC AGCCTCAGCC TCCTGGGCTC 840
AAGGGATCCT 850
|
